Notice of Change to section for RFA-DA-25-027: The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
Notice Number:
NOT-DA-23-064

Key Dates

Release Date:

February 7, 2024

Related Announcements

  • November 8, 2023 - The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required).  See NOFO RFA-DA-25-027

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of a change in the award budget language in the following notice of funding opportunity (NOFO) announcement: RFA-DA-25-027 "The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)"

Part 2. Full Text of Announcement

Section IV. Application and Submission Information

R&R Budget

Currently reads:

It is projected each PD/PI will require 2.4 - 4.2 (CY) person-months effort annually over the entire period of support to oversee the core functions of the award. 

Modified to read (in Bold Italic):

Each PD/PI must expend 2.4 - 4.2 (CY) person-months effort annually over the entire period of support to oversee the core functions of the award. 

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Betty Tai, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-2397
Email: btai@nida.nih.gov 


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices